United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,462 | -49,327 | 12,353 | 73,965 | 65,016 |
| Depreciation Amortization | 28,659 | 18,207 | 13,063 | 1,464 | 2,414 |
| Income taxes - deferred | -1,038 | -34,394 | -7,876 | -37,047 | -18,125 |
| Accounts receivable | -21,956 | -2,329 | -4,030 | -8,869 | -454 |
| Accounts payable and accrued liabilities | -3,645 | 18,509 | -1,072 | -1,082 | -2,122 |
| Other Working Capital | -51,290 | 17,805 | -5,803 | -5,305 | -7,041 |
| Other Operating Activity | 129,531 | -8,900 | 42,302 | 26,131 | 3,478 |
| Operating Cash Flow | $99,723 | $-40,429 | $48,937 | $49,257 | $43,166 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,551 | -314,113 | -243,936 | -118,355 | -64,625 |
| PPE Investments | -95,400 | -124,415 | -38,658 | -15,634 | -6,117 |
| Sale Of Investment | N/A | 266,051 | 260,888 | 32,360 | N/A |
| Purchase Sale Intangibles | -3,568 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -5,667 | -8,766 | 0 | 0 | 0 |
| Investing Cash Flow | $-162,618 | $-181,243 | $-21,706 | $-101,629 | $-70,742 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | 242,024 | N/A |
| Debt Repayment | 0 | 0 | N/A | -16 | -795 |
| Common Stock Issued | 32,071 | 191,936 | 58,344 | 14,445 | 14,965 |
| Common Stock Repurchased | N/A | N/A | -67,059 | -193,086 | N/A |
| Other Financing Activity | 4,406 | 21,090 | 29,604 | 10,761 | 0 |
| Financing Cash Flow | $36,477 | $213,026 | $20,889 | $74,128 | $14,170 |
| Exchange Rate Effect | -2,682 | -1,225 | 136 | 131 | N/A |
| Beginning Cash Position | 129,452 | 139,323 | 91,067 | 69,180 | 82,586 |
| End Cash Position | 100,352 | 129,452 | 139,323 | 91,067 | 69,180 |
| Net Cash Flow | $-29,100 | $-9,871 | $48,256 | $21,887 | $-13,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | 99,723 | -40,429 | 48,937 | 49,257 | 43,166 |
| Capital Expenditure | -95,400 | -124,415 | -38,658 | -15,634 | -6,117 |
| Free Cash Flow | 4,323 | -164,844 | 10,279 | 33,623 | 37,049 |